would you like to finance the development of highly active antiviral drugs?

Please give us a call!

Our hotline is available:

+49 176 2198 1495 und +49 176 2198 1496

Monday 10 am – 11 am CEST

Wednesday 10 am – 11 am CEST

Friday 10 am – 11 am, and 3 pm – 4 pm CEST

fax +49 2471 1356 067

E-mail: breun@sajo-innovation.com and baumann@sajo-innovation.com

Beyond these time frames you are welcome to leave a message on the answering machine, we will return your call within 24 hours.

We are looking for individuals, investors, institutions, foundations and banks, who are aware of the importance, while being financially strong partners.

Would you like to get highly active antiviral drugs for treatment and prophylaxis?

THIS IS WHAT SAJO OFFERS!

To that end, we are opening a call for a financial consortium.

We are extraordinary and we are thinking big.

We are looking for partners who want to take part in our big endeavor.

We are having the head start and we are thinking big: This is minimizing the risk of failure and is minimizing a time loss.

In the field that we are working in, YOUR risk is minimal. We are sure and we are confident in our capabilities.

Parameters: We need € 100 – 150 M now for the upcoming years to start the operative business. The amount will be used for a building with the necessary safety laboratories (€ 60 M including equipment) and the suitable infrastructure as well as the set-up of our proprietary technology, with personnel.

Would you or the respective institution like to profit through us and SAJO, our years long development of technology and business model? To you, this would be a relaxed one, for we are doing the job and we have made all the groundwork in long working hours over 20 years.

Please give us a call.

In the end we will have new antivirals for the current and the coming pandemics.

Please get into contact!

THINK BIG and BE SUCCESSFULL!

Enjoy the summer in the outdoors and keep the necessary distance. Keep your personal risk of infection as low as possible, since the long term consequences of an infection are not clear yet.